ACHV is trading 5.8% up at $6.91 as it extends a multi-day rally following its recent addition to the Russell 2000 and Russell 3000 Indexes.
- The inclusion in these major indices is expected to significantly boost the company's visibility and attract increased institutional ownership.
- Investor enthusiasm remains high regarding the cytisinicline nicotine-dependence program, supported by growing analyst optimism.
- ACHV continues to outperform broader market indices, which are currently trading slightly lower.